Patent · US Active

GDF11 variants and uses thereof

US11725033B2 · kind B2 · utility

0Cited by

2References

20Claims

0Family size

Assignee

President and Fellows of Harvard College · US

Inventors

Amy J. Wagers · Cambridge, US
Jill Goldstein · Boston, US
Ryan G. Walker · Brookline, US

Key dates

Filing date	Jul 20, 2020
Grant date	Aug 15, 2023
Priority date	—
Expiry date	Oct 12, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are GDF11 variant polypeptides. Also disclosed herein are methods for increasing GDF11 protein levels in a subject by administering a GDF11 variant polypeptide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.